This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
News-Medical.Net on MSN
Oxybutynin shows promise in managing hot flashes for prostate cancer patients
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Benign prostatic hyperplasia (BPH) and overactive bladder (OAB) syndrome are distinct health conditions but may cause similar symptoms, such as urgent or frequent urination. BPH is the noncancerous ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results